We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment

By HospiMedica International staff writers
Posted on 10 May 2024

A newly-developed gastrointestinal imaging capsule is poised to be a game-changer in esophagus surveillance and interventions.

The Multifunctional Ablative Gastrointestinal Imaging Capsule (MAGIC) developed by researchers from Johns Hopkins University (Baltimore, MD, USA) integrates cutting-edge optical coherence tomography (OCT) technology with a miniaturized endoscope camera and an ablation laser. This combination provides unparalleled capabilities for imaging and potentially treating the esophagus. With dual operating wavelengths of 800 and 1300 nm, MAGIC offers excellent resolution and imaging contrast, making it possible for physicians to spot early lesions with exceptional precision. The addition of an integrated ablation laser enhances MAGIC’s functionality, enabling the potential treatment of esophageal abnormalities during the same procedure used for detection.

MAGIC represents a significant advancement in meeting the clinical needs for a combined esophagus monitoring and treatment system. Existing tethered capsule endoscopy (TCE) technologies, though innovative, are hampered by inadequate resolution, imaging contrast, and the absence of visual guidance. MAGIC addresses these shortcomings, setting the stage for broader clinical use and improved patient outcomes. The researchers are optimistic about the transformative potential of MAGIC and are eager to continue its development and clinical implementation. This pioneering technology is poised to revolutionize esophageal health care and significantly improve the lives of patients across the world.

Related Links:
Johns Hopkins University

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Ultrasonic Cleaners
Large-Capacity Ultrasonic Cleaners
New
Electrocardiograph
BeneHeart R700/R900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.